Clinical Trials Directory

Trials / Completed

CompletedNCT02750748

Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
14 (actual)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

To determine the pharmacokinetics of 2 intranasal doses and 1 oral dose of naltrexone compared to an intramuscular dose of naltrexone.

Conditions

Interventions

TypeNameDescription
DRUGNaltrexone
OTHERIntravail

Timeline

Start date
2016-07-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2016-04-25
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02750748. Inclusion in this directory is not an endorsement.

Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers (NCT02750748) · Clinical Trials Directory